Clinical Trial Update: A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates LN-144 or LN-145 in people with advanced uveal melanoma, undifferentiated pleomorphic sarcoma, dedifferentiated liposarcoma, or mel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dedifferentiated Liposarcoma
• Melanoma
• Undifferentiated Pleomorphic Sarcoma
• Uveal Melanoma

Drugs mentioned

• LN-144
• LN-145 (autologous tumor-infiltrating lymphocytes)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Uveal Melanoma, Melanoma | Phase 1 | Status: RECRUITING